Patient care navigation and health copilot AI
Neatly Health
Neatly supports patient-selected records and sharing. Optional identifiable sharing must be distinguished from population insights. The review corrects blanket sharing claims and outdated caregiver-feature descriptions, while keeping source and correction gaps explicit.
Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.
Summary judgment · 82 out of 100 toward patient-directed
Patient-initiated recording, summaries and health questions, with separate cohort-insight commercialization and optional third-party opportunities.
Potentially agency-expanding, with data-commercialization caveat
Neatly supports patient-selected records and sharing. Optional identifiable sharing must be distinguished from population insights. The review corrects blanket sharing claims and outdated caregiver-feature descriptions, while keeping source and correction gaps explicit.
Patient agency
How this tool changes agency
A retained visit account can support questions and challenge misunderstandings. Cohort patterns are not necessarily comparable treatment evidence, and per-answer source links remain unverified.
Transcript editing, source links, aggregate-use refusal and third-party processing specifics remain unresolved
Patient agency assessment
Who sets and changes the goal?
Patients initiate recording and questions and can reuse summaries. The public pass does not establish editable transcripts or control over all cohort-derived uses.
What can the patient understand, question, or do?
A retained visit account can support questions and challenge misunderstandings. Cohort patterns are not necessarily comparable treatment evidence, and per-answer source links remain unverified.
Can the patient evaluate the conditions of use?
The FAQ's blanket no-individual-sharing language needs the policy's explicit optional sharing exception. Sponsor non-influence is a vendor statement, not independently verified neutrality.
Text findings
Conditions of use
Published controls and their limits
The FAQ's blanket no-individual-sharing language needs the policy's explicit optional sharing exception. Sponsor non-influence is a vendor statement, not independently verified neutrality.
What remains unknown?
Not tested or not established
Transcript editing, source links, aggregate-use refusal and third-party processing specifics remain unresolved
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Transcript editing, source links, aggregate-use refusal and third-party processing specifics remain unresolved No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
AI-assisted draft · Moderate for public product and policy descriptions (AI-assisted draft)